Dr. David Alan Ginsberg, MD

Dr. Ginsberg practices at Urology - Nch Urology - HOPD in Los Angeles, California.

Dr. Ginsberg's NPI, 1073534525, was assigned on July 21, 2006. Dr. Ginsberg graduated from Keck School of Medicine of USC in 1990. Dr. Ginsberg holds California license G72638.

Dr. Ginsberg's primary practice is Urology - Nch Urology - HOPD, at 1516 San Pablo St, Los Angeles, CA 90033.

Dr. Ginsberg's primary practice is Urology - Nch Urology - HOPD in Los Angeles, California. Dr. Ginsberg is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Ginsberg to 2 more hospitals, 2 hospital outpatient departments, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ginsberg practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ginsberg's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Ginsberg is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dr. Ginsberg is licensed in California.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, pelvic prolapse and urinary endoscopy among the conditions Dr. Ginsberg treats.

CMS data shows 1,644 Medicare services from Dr. Ginsberg across 17 procedure codes in 2024, for 651 Medicare patients. Medicare paid $111,472 for them.

CMS counts 651 Medicare patients who saw Dr. Ginsberg in 2024. The largest group is 65 to 74, with 237 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ginsberg's median patient age at 69, with 51% women.

In 2024, Dr. Ginsberg wrote 911 Medicare Part D claims for 282 patients. 63% of them were for generic drugs. CMS names the drug for 831 of them, across 13 drugs with 11 or more claims each, at $189,120 in total drug cost. In 2023, CMS named 713 claims across 13 drugs.

Dr. Ginsberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ginsberg as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Ginsberg, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Ginsberg, published from 2012 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Urology. Dr. Ginsberg has published most often in Neurourol Urodyn. Dr. Ginsberg's most frequent co-authors are Christopher J. Chermansky, MD, Ekene Ada Enemchukwu, MD and Angelo E. Gousse, MD.

CMS Open Payments shows 236 general payments to Dr. Ginsberg from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 33% of the total. Avadel Specialty Pharmaceuticals, LLC paid the most, $12,152.

Dmand AI lists 2 awards for Dr. Ginsberg.

Dr. Ginsberg graduated from Keck School of Medicine of USC in 1990. Dr. Ginsberg is a member of ACS.

Dr. Ginsberg is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.